LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in LENZ Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- +9 vs. Q2 2021
- Shares held
- 36.0M
- +3.78M (+11.7%) vs. Q2 2021
- Total value
- $587.4M
- −$394.1M (−40.2%) vs. Q2 2021
- New holders
- 29
- 12 more added
- Sold out
- 20
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Portfolios Advisors | 20 | $328 | 0.00% | +20 | New |
| Federation des caisses Desjardins du Quebec | 200 | $3.28K | 0.00% | +200 | New |
| Tower Research Capital LLC (TRC) | 681 | $11.0K | 0.00% | +681 | New |
| Ameritas Investment Partners, Inc. | 1,246 | $20.0K | 0.00% | +1,246 | New |
| Advisor Group Holdings, Inc. | 1,320 | $22.0K | 0.00% | +1,320 | New |
| Legal & General Group Plc | 1,519 | $25.0K | 0.00% | +1,519 | New |
| Citigroup Inc | 1,887 | $31.0K | 0.00% | +1,887 | New |
| Royal Bank of Canada | 1,916 | $32.0K | 0.00% | +1,884+5,887.5% | Added |
| UBS Group AG | 2,509 | $41.0K | 0.00% | +2,509 | New |
| Wells Fargo & Company | 2,952 | $48.0K | 0.00% | +2,952 | New |
| STRS Ohio | 3,700 | $60.0K | 0.00% | +3,700 | New |
| Point72 Asset Management, L.P. | 5,000 | $82.0K | 0.00% | −5,000−50.0% | Reduced |
| Metropolitan Life Insurance Co | 5,191 | $85.1K | 0.00% | +5,191 | New |
| New York State Common Retirement Fund | 5,700 | $93.0K | 0.00% | +5,700 | New |
| JPMorgan Chase & Co | 6,224 | $102.0K | 0.00% | +6,224 | New |
| MetLife Investment Management | 6,861 | $112.5K | 0.00% | +6,861 | New |
| SG Americas Securities, LLC | 7,247 | $119.0K | 0.00% | +7,247 | New |
| Cubist Systematic Strategies, LLC | 8,677 | $142.0K | 0.00% | +8,677 | New |
| California State Teachers Retirement System | 8,780 | $144.0K | 0.00% | +8,780 | New |
| American International Group, Inc. | 8,893 | $146.0K | 0.00% | +8,893 | New |
| Deutsche Bank AG | 9,347 | $153.0K | 0.00% | +9,347 | New |
| Cetera Advisor Networks LLC | 11,400 | $187.0K | 0.00% | +11,400 | New |
| Rhumbline Advisers | 11,746 | $193.0K | 0.00% | +11,746 | New |
| Ghisallo Capital Management LLC | 15,000 | $246.0K | 0.01% | −25,000−62.5% | Reduced |
| Bank of America Corp | 30,513 | $500.0K | 0.00% | +30,313+15,156.5% | Added |
| Nuveen Asset Management, LLC | 34,311 | $562.0K | 0.00% | +34,311 | New |
| Bank of New York Mellon Corp | 39,394 | $646.0K | 0.00% | +39,394 | New |
| Charles Schwab Investment Management Inc | 39,797 | $653.0K | 0.00% | +39,797 | New |
| Caas Capital Management LP | 40,000 | $656.0K | 0.05% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 53,472 | $876.0K | 0.00% | +53,472 | New |
| HighVista Strategies LLC | 60,905 | $998.0K | 0.66% | +60,905 | New |
| Goldman Sachs Group Inc | 74,109 | $1.22M | 0.00% | −200,317−73.0% | Reduced |
| Northern Trust Corp | 143,199 | $2.35M | 0.00% | +143,199 | New |
| State Street Corp | 196,641 | $3.22M | 0.00% | +196,641 | New |
| Cormorant Asset Management, LP | 203,153 | $3.26M | 0.13% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 257,376 | $4.22M | 0.00% | +257,376 | New |
| Jennison Associates LLC | 296,375 | $4.86M | 0.00% | −3,625−1.2% | Reduced |
| Woodline Partners LP | 300,031 | $4.92M | 0.08% | −9,692−3.1% | Reduced |
| Morgan Stanley | 413,765 | $6.78M | 0.00% | +150,263+57.0% | Added |
| UBS Asset Management Americas Inc | 442,704 | $7.26M | 0.00% | +48,917+12.4% | Added |
| Sphera Funds Management Ltd. | 531,269 | $8.71M | 0.86% | +506,312+2,028.7% | Added |
| Millennium Management LLC | 541,147 | $8.87M | 0.01% | −48,686−8.3% | Reduced |
| Norges Bank | 554,167 | $9.08M | 0.00% | −145,833−20.8% | Reduced |
| Vanguard Group Inc | 696,431 | $11.4M | 0.00% | +666,431+2,221.4% | Added |
| Artal Group S.A. | 700,000 | $11.5M | 0.28% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 703,071 | $11.5M | 0.86% | −630−0.1% | Reduced |
| Avidity Partners Management LP | 748,995 | $12.3M | 0.31% | +13,495+1.8% | Added |
| Perceptive Advisors LLC | 875,093 | $14.3M | 0.21% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 906,308 | $14.9M | 0.29% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 958,079 | $15.2M | 0.01% | −292,926−23.4% | Reduced |
| BlackRock Inc. | 949,914 | $15.6M | 0.00% | +846,333+817.1% | Added |
| Federated Hermes, Inc. | 1,056,308 | $17.3M | 0.03% | +406,308+62.5% | Added |
| Logos Global Management LP | 1,206,308 | $19.8M | 1.43% | +135,546+12.7% | Added |
| Citadel Advisors LLC | 1,270,173 | $20.5M | 0.02% | −18,052−1.4% | Reduced |
| OrbiMed Advisors LLC | 1,449,904 | $23.8M | 0.26% | +343,597+31.1% | Added |
| VR Adviser, LLC | 1,612,617 | $26.4M | 3.39% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 2,076,710 | $34.0M | 0.72% | −75,028−3.5% | Reduced |
| Ra Capital Management, L.P. | 2,698,369 | $44.2M | 0.61% | 00.0% | Unchanged |
| FMR LLC | 6,249,606 | $101.1M | 0.01% | +2,487,627+66.1% | Added |
| Samsara BioCapital, LLC | 7,431,623 | $121.8M | 20.22% | 00.0% | Unchanged |
| SB Management Ltd | 0 | $0 | 0.00% | −993,402−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −52,543−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | 0 | $0 | 0.00% | −51,039−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −36,646−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −19,232−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,225−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,700−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −7,709−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,576−100.0% | Sold out |